TREATMENT OF METASTATIC MELANOMA WITH INTERLEUKIN-2

被引：0
作者：
CHOSIDOW, O
GUILLAUME, JC
机构：
[1] HOP HENRI MONDOR,SERV DERMATOL,F-94010 CRETEIL,FRANCE
[2] INST GUSTAVE ROUSSY,SERV DERMATOL,F-94805 VILLEJUIF,FRANCE
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 1992年 / 119卷 / 01期
关键词：
MALIGNANT MELANOMA; INTERLEUKIN-2;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：65 / 73
页数：9
相关论文
共 50 条
[21]   SEQUENTIAL DACARBAZINE CISPLATIN AND INTERLEUKIN-2 IN METASTATIC MELANOMA - IMMUNOLOGICAL EFFECTS OF THERAPY [J].
REDMAN, BG ;
FLAHERTY, L ;
CHOU, TH ;
NAKEFF, A ;
PILLOTE, K ;
KAPLAN, J .
JOURNAL OF IMMUNOTHERAPY, 1991, 10 (02) :147-151
[22]   Carboplatin and Vinorelbine Combined with Subcutaneous Interleukin-2 in Metastatic Melanoma with Poor Prognosis [J].
Vuoristo, Meri-Sisko ;
Vihinen, Pia ;
Skytta, Tanja ;
Tyynela, Kristiina ;
Kellokumpu-Lehtinen, Pirkko .
ANTICANCER RESEARCH, 2009, 29 (05) :1755-1759
[23]   Activity of continuous infusion plus pulse interleukin-2 with famotidine in patients with metastatic kidney cancer or melanoma previously treated with interleukin-2 [J].
Quan, Walter D. Y., Jr. ;
Walker, Paul R. ;
Quan, Francine M. ;
Ramirez, Maria ;
Elsamaloty, Haitham M. ;
Ghai, Vikas ;
Vinogradov, Mikhail ;
Liles, Darla K. .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (05) :437-442
[24]   Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma [J].
M Lotem ;
E Shiloni ;
I Pappo ;
O Drize ;
T Hamburger ;
R Weitzen ;
R Isacson ;
L Kaduri ;
S Merims ;
S Frankenburg ;
T Peretz .
British Journal of Cancer, 2004, 90 :773-780
[25]   ACUTE RHABDOMYOLYSIS AFTER CONCURRENT ADMINISTRATION OF INTERLEUKIN-2, INTERFERON-ALFA, AND CHEMOTHERAPY FOR METASTATIC MELANOMA [J].
ANDERLINI, P ;
BUZAID, AC ;
LEGHA, SS .
CANCER, 1995, 76 (04) :678-679
[26]   Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma [J].
Lotem, M ;
Shiloni, E ;
Pappo, I ;
Drize, O ;
Hamburger, T ;
Weitzen, R ;
Isacson, R ;
Kaduri, L ;
Merims, S ;
Frankenburg, S ;
Peretz, T .
BRITISH JOURNAL OF CANCER, 2004, 90 (04) :773-780
[27]   GROWTH AND AUTOLOGOUS TUMOR LYSIS BY TUMOR-INFILTRATING LYMPHOCYTES FROM METASTATIC MELANOMA EXPANDED IN INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERLEUKIN-4 [J].
LINDGREN, CG ;
THOMPSON, JA ;
HIGUCHI, CM ;
FEFER, A .
JOURNAL OF IMMUNOTHERAPY, 1993, 14 (04) :322-328
[28]   Effect of Interferon-α-2b and Interleukin-2 Combined with Chemotherapy in Metastatic Melanoma [J].
Su, Zheng ;
Shi, Fen ;
Zhang, Jian ;
Liang, Weiqiang .
PANMINERVA MEDICA, 2020, :131-136
[29]   Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2 [J].
Glitza, Isabella C. ;
Rohlfs, Michelle ;
Guha-Thakurta, Nandita ;
Bassett, Roland L. ;
Bernatchez, Chantale ;
Diab, Adi ;
Woodman, Scott E. ;
Yee, Cassian ;
Amaria, Rodabe N. ;
Patel, Sapna P. ;
Tawbi, Hussein ;
Wong, Michael ;
Hwu, Wen-Jen ;
Hwu, Patrick ;
Heimberger, Amy ;
McCutcheon, Ian E. ;
Papadopoulos, Nicholas ;
Davies, Michael A. .
ESMO OPEN, 2018, 3 (01)
[30]   Scalp In-Transit Metastatic Melanoma Treated with Interleukin-2 and Pulsed Dye Laser [J].
Wang, Michael Z. ;
Brewer, Jerry D. .
HEALTHCARE, 2013, 1 (01) :96-99
12345